We are live on ! Find out more
CRNX icon

Crinetics Pharmaceuticals
CRNX

83 hedge funds and large institutions have $661M invested in Crinetics Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

262% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 13

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

42% more capital invested

Capital invested by funds: $465M → $661M (+$196M)

33% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 9

4% more funds holding

Funds holding: 80 → 83 (+3)

5.91% less ownership

Funds ownership: 93.35% → 87.44% (-5.9%)

Holders
83
Holders Change
+3
Holders Change %
+3.75%
% of All Funds
1.44%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
12
Increased
47
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
Driehaus Capital Management
Illinois
+$12.4M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$10.7M
3
BlackRock
BlackRock
New York
+$7.5M
4
SFM
Sphera Funds Management
Israel
+$6.15M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
VVM
Versant Venture Management
California
-$21.3M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.96M
3
VC
Vivo Capital
California
-$8.11M
4
NHAS
Novo Holdings A/S
Denmark
-$4.15M
5
EAM
Eventide Asset Management
Massachusetts
-$3.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
QT
76
Quantbot Technologies
New York
$13K +$12.3K +700 New
S
77
SignatureFD
Georgia
$5K – – –
US Bancorp
78
US Bancorp
Minnesota
$4K +$1.35K +77 +68%
TWA
79
TCI Wealth Advisors
Arizona
$2K +$2.07K +118 New
Daiwa Securities Group
80
Daiwa Securities Group
Japan
$1K – – –
SOW
81
State of Wyoming
Wyoming
$1K +$914 +52 New
AIG
82
American International Group
New York
$385 +$82K +4,668 +30%
NHAS
83
Novo Holdings A/S
Denmark
– -$4.15M -271,378 Closed
EAM
84
Eventide Asset Management
Massachusetts
– -$3.69M -241,140 Closed
California Public Employees Retirement System
85
California Public Employees Retirement System
California
– -$837K -54,800 Closed
Russell Investments Group
86
Russell Investments Group
United Kingdom
– -$213K -14,001 Closed
Wells Fargo
87
Wells Fargo
California
– -$79K -5,195 Closed
UBS Group
88
UBS Group
Switzerland
– -$63K -4,129 Closed
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
– -$13K -731 Closed
PAM
90
Panagora Asset Management
Massachusetts
– -$5K -324 Closed
AIC
91
Ameritas Investment Company
Nebraska
– -$4.58K -300 Closed
1 2 3
4

CRNX Hedge Fund Activity: Q2 2021 in Review

83 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Crinetics Pharmaceuticals (CRNX) for Q2 2021, worth a combined $661M — up 42% from $465M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CRNX positions and 9 closed out — a net gain of 3 holders — while 47 added to existing stakes and 13 trimmed.

The largest buyer was Driehaus Capital Management, adding an estimated $12.4M. The largest seller was Versant Venture Management, cutting an estimated $21.3M.

  • 83 institutional investors held Crinetics Pharmaceuticals (CRNX) as of Q2 2021, up from 80 in Q1 2021.
  • Funds reported $661M of Crinetics Pharmaceuticals stock for Q2 2021, up 42% quarter-over-quarter.
  • 12 funds opened new Crinetics Pharmaceuticals positions in Q2 2021 and 9 closed out, a net change of +3 holders.
  • The largest Crinetics Pharmaceuticals buyer in Q2 2021 was Driehaus Capital Management, an estimated $12.4M added.
  • The largest Crinetics Pharmaceuticals seller in Q2 2021 was Versant Venture Management, an estimated $21.3M sold.

Based on aggregated 13F filings for Q2 2021.